Nik Nor Izah Nik Ibrahim

Dr. Nik Nor Izah Nik Ibrahim

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2015 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
SFSiew Wai Fong
Siew Wai Fong
LFLing Ling Few
Ling Ling Few
WTWei Cun See Too
Wei Cun See Too
KYKhoo Boon Yin
Khoo Boon Yin
NINik Nor Izah Nik Ibrahim
Nik Nor Izah Nik Ibrahim
YBYvonne-Tee Get Bee
Yvonne-Tee Get Bee
Biomarkers play a pivotal role in the diagnosis and management of patients with acute coronary syndrome. This study aimed to investigate the differences in level of several biomarkers, i.e. C-reactive protein, myeloperoxidase, soluble CD40 ligand and placental growth factor, between acute coronary syndrome and chronic stable angina patients. The relationship between these biomarkers in the coronary circulation and systemic circulation was also investigated. A total of 79 patients were recruited in this study. The coronary blood was sampled from occluded coronary artery, while the peripheral venous blood was withdrawn from antecubital fossa. The serum concentrations of C-reactive protein, soluble CD40 ligand and placental growth factor and plasma concentration of myeloperoxidase were measured using ELISA method. The systemic level of the markers measured in the peripheral venous blood was significantly increased in acute coronary syndrome compared to chronic stable angina patients. The concentrations of the C-reactive protein, myeloperoxidase and soluble CD40 ligand taken from peripheral vein were closely similar to the concentration found in coronary blood of ACS patients. The level of placental growth factor was significantly higher in coronary circulation than its systemic level. The concentration of these C-reactive protein, myeloperoxidase, soluble CD40 ligand and placental growth factor were significantly increased in acute coronary syndrome patients. The concentration of the markers measured in the systemic circulation directly reflected those in the local coronary circulation. Thus, these markers have potential to become a useful tool in predicting plaque vulnerability in the future.

19 June 2022 in Medicina
Verified
Journal Article
Open access
PDF file
NINik Nor Izah Nik Ibrahim
Nik Nor Izah Nik Ibrahim
RRRazlina Abdul Rahman
Razlina Abdul Rahman
MARYAM AZLANMARYAM AZLAN
MARYAM AZLAN
AAAniza Abd Aziz
Aniza Abd Aziz
ARAida Hanum Ghulam Rasool
Aida Hanum Ghulam Rasool
Background and Objectives: Endothelial microparticles (EMP) particularly CD31+/42−/AV+, CD144+/AV+ and CD62e+/AV+ have been reported as having increased in cardiovascular-related diseases, making them potential biomarkers for endothelial dysfunction. This study aimed to compare these EMPs in patients with hypercholesterolemia and healthy controls and to correlate their levels with endothelium-dependent vasodilation (EDV) assessed via pulse wave analysis (PWA); an established method of assessing endothelial function. Materials and Methods: EMPs from 88 subjects (44 hypercholesterolemia patients and 44 controls) were quantified from whole blood using flow cytometry analysis. Endothelial function was determined using PWA combined with pharmacological challenge. Results: CD31+/42−/AV+ (3.45 ± 4.74 count/µL vs. 1.33 ± 4.40 count/µL; p = 0.03), CD144+/AV+ (7.37 ± 12.66 count/µL vs. 1.42 ± 1.71 count/µL; p = 0.003) and CD62e+/AV+ (57.16 ± 56.22 count/µL vs. 20.78 ± 11.04 count/µL; p < 0.001) were significantly elevated in the hypercholesterolemic group compared with the controls, respectively. There was a significant inverse moderate correlation between all circulating EMPs and EDV: CD31+/42−/AV+ (r = −0.36, p = 0.001), CD144+/AV+ (r = −0.37, p = 0.001) and CD62e+/AV+ (r = −0.35, p = 0.002). Conclusions: All EMPs were raised in the patients with hypercholesterolemia, and these values correlated with the established method of assessing endothelial function.

1 January 2007 in Methods and Findings in Experimental and Clinical Pharmacology
Verified
Journal Article
Closed access
NINik Nor Izah Nik Ibrahim
Nik Nor Izah Nik Ibrahim
ARA.H.G. Rasool
A.H.G. Rasool
AWA.R. Wong
A.R. Wong
ARA.R.A. Rahman
A.R.A. Rahman
Pulse-wave analysis (PWA) combined with pharmacological challenges has recently been used as a method to measure endothelial function. This involved administration of glyceryl trinitrate (GTN), followed by salbutamol as endothelium-independent and -dependent vasodilators, respectively. The duration of GTN effect needs to be established before the administration of salbutamol. Baseline augmentation index (AIx) and pulse-wave velocity (PWV) measurements were taken in 11 healthy female subjects (mean age 23.27 +/- 3.66 years). Sublingual GTN 0.5 mg was administered for 3 min, followed by AIx and PWV measurements every 5 min till 20 min and then every 10 min until 40 min post-GTN. Maximum change in AIx post-GTN was at 3 min with a mean change from the baseline of -17.86% +/- 4.40% (p < 0.001). There were no significant changes noted after 30 and 40 min with mean change being -0.82% +/- 2.61% and 0.14% +/- 3.20%, respectively (p > 0.05). Significant changes in PWV were noted at 5 and 10 min with the mean change of -0.33 +/- 0.36 m/s and -0.33 +/- 0.35 m/s, respectively (p = 0.01). There were no further changes noted at 15 min and thereafter (p > 0.05). A duration of at least 30 min after GTN is required for AIx and PWV values to reach their baseline. Thus, the administration of salbutamol should be given only after 30 min of sublingual GTN for the assessment of endothelial function.

1 July 2023 in Annals of Animal Science
Verified
Journal Article
Open access
PDF file
MNMuhammad Luqman Nordin
Muhammad Luqman Nordin
Ahmad Khusairi AzemiAhmad Khusairi Azemi
Ahmad Khusairi Azemi
NINoraznawati Ismail
Noraznawati Ismail
ANAbu Hassan Nordin
Abu Hassan Nordin
WNWalid Nabgan
Walid Nabgan
NINik Nor Izah Nik Ibrahim
Nik Nor Izah Nik Ibrahim
Canine mammary carcinoma (CMC) is the most common neoplasm in bitches, and it shares many biological similarities with breast cancer in humans. Drug resistance, high epigenetic mutations, and relapse rates are among the challenges which eventually urge the need for a veterinary oncologist to discover new therapeutic approaches that are more effective and safer. Therefore, in this review, we also cover the current therapeutic strategies from human medicine for the future perspectives of tumor immunotherapy in veterinary medicine. These strategies have great potential to be employed as therapeutic or prophylactic options due to their ability to modulate a specific and potent immune response against CMC. As we acquire a better understanding of canine tumor immunology, we can move towards a brighter prognosis. Additionally, we report on the recent successful studies in breast cancer that may benefit canines as well.

3 November 2009 in Clinica Chimica Acta
Verified
Journal Article
Closed access
NINik Nor Izah Nik Ibrahim
Nik Nor Izah Nik Ibrahim
ARAida Hanum Ghulam Rasool
Aida Hanum Ghulam Rasool
AWAbdul Rahim Wong
Abdul Rahim Wong
ARAbdul Rashid Abdul Rahman
Abdul Rashid Abdul Rahman

20 November 2016 in Skin Research and Technology
Verified
Journal Article
Closed access
PDF file
NINik Nor Izah Nik Ibrahim
Nik Nor Izah Nik Ibrahim
ARA. H. G. Rasool
A. H. G. Rasool